Decatur, Georgia 30033

  • Thrombosis


Patients who undergo total hip replacement surgery are at greater risk of getting deep vein thrombosis (blood clots). This study evaluates the safety, tolerability and effectiveness of the study drug, DU-176b, in reducing the occurrence of deep vein thrombosis in patients having total hip replacement surgery.

Study summary:

The primary study objective is to demonstrate prevention of venous thromboembolism in patients undergoing total hip replacement surgery. The secondary objective is to assess the safety and tolerability of DU-176.


Inclusion Criteria: - Unilateral hip replacement Exclusion Criteria: - Patients scheduled for bilateral hip replacement in same procedure - Patients with increased risk of bleeding - Uncontrolled hypertension (BP greater than 180/100 mmHg) - Patients less than 111 lbs or more than 243 lbs - Patients on long-term anticoagulants - Patients with contraindications to venography - Patients with medical history of venous thromboembolism - Patients with impaired hepatic function - Known to be pregnant - Lactating women



Primary Contact:


Backup Contact:


Location Contact:

Decatur, Georgia 30033
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: April 03, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.